A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
Clinical trial NCT02536833 · COMPLETED
Trial details
- NCT number
- NCT02536833
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-09
- Primary completion
- 2017-04-20
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.